Vulcan Energy (ASX: VUL) Taps Markets for $1B, But at a Heavy Discount

Charlie Youlden Charlie Youlden, December 4, 2025

Vulcan’s $1B Raise Comes at a 34% Discount

Vulcan (ASX: VUL) announced today that it has completed its institutional placement at an offer price of A$4 per share. This represents a steep 34% discount to the last traded price of A$6.31 and a 21 percent discount to the theoretical ex-rights price of A$5.06. The institutional component raised A$710 million, with a retail offer still to come that aims to bring in a further A$366 million. In total, the company is targeting close to A$1 billion in new equity.

If fully subscribed, the raise will result in roughly 268 million new shares entering the market. For investors, the scale of the dilution is significant, but it also highlights the size of the capital injection that Culvan is seeking to fund its next phase of growth.

What are the Best ASX Stocks to invest in right now?

Check our buy/sell tips

$3.9B Lionheart Project Targets Zero-Carbon Lithium

The capital raising sits within Vulcan’s broader €2.2 billion, or roughly A$3.9 billion, Phase One financing package for its Lionheart Project in Germany, which is set to become Europe’s first fully integrated zero carbon lithium and renewable energy development. The A$4 offer price comes at a steep 35 percent discount to the pre announcement market price. It is highly dilutive in the near term, but it has been structured this way to maximise participation, secure long term funding certainty, and attract new strategic institutions that want exposure to European battery materials.

At full scale, Lionheart is designed to produce 24,000 tonnes per annum of lithium hydroxide monohydrate. That is the equivalent of supplying about 500k electric vehicle batteries each year. Alongside lithium production, the project will generate an estimated 275 gigawatt hours of renewable electricity and 560 gigawatt hours of renewable heat annually for surrounding communities. With a planned mine life of thirty years, it positions Vulcan as the leading lithium developer in Europe with sovereign and institutional backing.

What can investors expect to come for VUL

The discount also aims to draw in new institutional investors, including potential strategic partners in Europe, while recognising that the company is still in a high risk project execution phase. When trading resumes, the share price would usually drift toward the theoretical ex rights price of A$5.06 as the discounted issuance is absorbed into the capital structure.

It is also common for sentiment driven selling to push the share price even closer to the offer price of A$4. This typically reflects short term supply overhang from the large volume of new shares entering the market and profit taking from institutions that secured discounted allocations. For investors, this period often brings volatility but also sets a clearer base from which the project can be funded and advanced.

Blog Categories

Get Our Top 5 ASX Stocks for FY26

Recent Posts

Cynata

Cynata Therapeutics Completes Phase 2 Enrollment- Buy Before June or Wait for the Data?

Cynata Therapeutics (ASX: CYP) has completed patient enrollment in its Phase 2 clinical trial of CYP-001 for acute graft versus…

Medallion

Medallion Metals’ $60M War Chest Sets Up 2026 Production Push- Is the Stock a Buy?

Medallion Metals (ASX: MM8) has secured an A$60 million funding package, with Lion Selection Group committing A$5 million to the…

Neuren

Neuren Pharmaceuticals (ASX:NEU) Gets FDA Approval- Is It a Buy?

Neuren Pharmaceuticals (ASX: NEU) rose 2.5% yesterday after the US FDA approved DAYBUE STIX, a new powder formulation of its…